Viatris Inc. (VTRS)

Market Cap	11.66B
Revenue (ttm)	14.12B
Net Income (ttm)	-3.69B
Shares Out	1.15B
EPS (ttm)	-3.13
PE Ratio	n/a
Forward PE	4.25
Dividend	$0.48 (4.74%)
Ex-Dividend Date	Nov 24, 2025

Volume	12,725,925
Open	10.09
Previous Close	10.11
Day's Range	9.92 - 10.16
52-Week Range	6.85 - 13.55
Beta	0.84
Analysts	Hold
Price Target	11.17 (+10.38%)
Earnings Date	Nov 6, 2025

About VTRS

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1961
• Employees: 32,000
• Stock Exchange: NASDAQ
• Ticker Symbol: VTRS
• Website: https://www.viatris.com

Analyst Summary

According to 6 analysts, the average rating for VTRS stock is "Hold." The 12-month stock price target is $11.17, which is an increase of 10.38% from the latest price.

Price Target

$11.17

(10.38% upside)

Analyst Consensus: Hold